FDA Drug Application (200623) for LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE by CIPLA LIMITED

Back to FDA Applications sponsored by CIPLA LIMITED

Application Number200623
Product Number001
FormTABLET; ORAL
Dosage300MG; 300MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
Active IngredientLAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE

Active IngredientCount
List of drugs with Active Ingredient LAMIVUDINE39
List of drugs with Active Ingredient TENOFOVIR DISOPROXIL FUMARATE15


Back to FDA Applications sponsored by CIPLA LIMITED